ArticleJournal of cellular and molecular medicine2026
RETRACTION: Silencing CDR1as Enhances the Sensitivity of Breast Cancer Cells to Drug Resistance by Acting as a miR-7 Sponge to Down-Regulate REGγ.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionW. Yang, X. Yang, X. Wang, J. Gu, D. Zhou, Y. Wang, B. Yin, J. Guo and M. Zhou, "Silencing CDR1as Enhances the Sensitivity of Breast Cancer Cells to Drug Resistance by Acting as a miR-7 Sponge to Down-Regulate REGγ," Journal of Cellular and Molecular Medicine 23, no. 8 (2019): 4921-4932, https://doi.org/10.1111/jcmm.14305. The above article, published online on 27 June 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed following concerns raised by a third party. An investigation identified multiple instances of duplication within Figures 2B, 5B and 6B as well as duplication between Figures 2B and 5B. The authors were contacted and invited to comment on the concerns and to provide supporting data, but no response was received. The editors no longer have confidence in the reliability of the findings reported in the article. The authors did not respond to our notice of retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.